Graft-versus-leukaemia

Bailliere's Clinical Haematology

Volumn 10, Issue 2, 1997, Pages 337-355

  Barrett, A J ^a   Van Rhee, F ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Adoptive immunotherapy; Chronic myeloid leukaemia; Graft versus leukaemia; Grait versus host disease; Leukaemic relapse

Indexed keywords

CD4 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; DONOR; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LYMPHOCYTE TRANSFUSION; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; REVIEW; T LYMPHOCYTE;

EID: 0030804130     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80011-X     Document Type: Article

References (95)

1. Apperley JF Jones L Hale G Goldman JM Bone marrow transplantation for chronic myeloid leukaemia: T cell depletion with Campath-1 reduces the incidence of acute graft-versus-host disease but may increase the risk of leukaemic relapse Bone Marrow Transplantation 1 1986 53 66
2. Barnes D Loutit J Treatment of murine leukemia with x-rays and homologous bone marrow British Journal of Haematology 3 1957 241 252
3. Barrett AJ Jiang YZ Immune responses to chronic myeloid leukemia Bone Marrow Transplantation 9 1992 305 311
4. Behar E Chao NJ Hiraki DD Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease New England Journal of Medicine 334 1996 286 291
5. Blaise D Olivier D Michallet M Impairment of leukaemia-free survival by addition of interleukin-2 receptor antibody to standard graft-versus-host prophylaxis Lancet 345 1995 1144 1146
6. Bocchia M Korontsvit T Xu Q Specific human cellular immunity to bcr/abl oncogene-derived peptides Blood 87 1996 3587 3592
7. Bortin MM Horowitz MM Rowlings PA Special report: 1993 progress report from the International Bone Marrow Transplant Registry Bone Marrow Transplantation 12 1993 97 104
8. ten Bosch GJA Joosten AM Kessler OH Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide Blood 88 1996 3522 3530
9. de Buerger M Bakker A van Rood J Tissue distribution of human minor histocompatibility antigens Journal of Immunology 149 1992 1788 1794
10. Cavazzana-Calvo M Stephan JL Sarnacki S Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination Blood 83 1994 288 298
11. Champlin R Ho W Gajewski J Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation Blood 78 1990 416 423
12. Champlin R Pasweg J Horowitz M T-cell depleted (TCD) BMT for leukemia patients with donors other than identical siblings Blood 88 supplement 1 1995 94a
13. BCR-ABL protein Proceedings of the National Academy of Sciences of the USA 89 1992 1468 1475
14. Choudhury A Gajewski JL Liang JL Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia-chromosome positive chronic myelogenous leukemia Blood 89 1997 1133 1142
15. Collins RH Rogers ZR Bennet M Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression Bone Marrow Transplantation 10 1992 391 395
16. Cross N Feng L Chase A Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation Blood 82 1993 1929 1936
17. Datta AR Barrett AJ Jiang YZ Distinct T cell populations distinguish chronic myeloid leukemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions Bone Marrow Transplantation 14 1994 517 524
18. Delain M Tiberghien P Racadot E Variability of the alloreactive T-cell response to human leukemic blasts Leukemia 8 1994 642 647
19. DermiMe S Barrett AJ Gambacorti-Passerini C The role of the immune system in anti-tumour responses: potential for drug therapy Drugs and Aging 7 1995 266 277
20. Dermime S Molldrem J Parker KC Human CD8+ T lymphocytes recognize the fusion region of BCR/ABL hybrid protein present in chronic myelogenous leukemia Blood 86 supplement 1 1995 158a
21. Dermime S Hensel N Jiang YZ Does immune escape from a graft-versus-leukemia effect play a role in the relapse of myelogenous leukemias following allogeneic bone marrow transplantation? Bone Marrow Transplantation 19 10 1997 989 999
22. Drobyski W Keever C Roth M Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood 82 1993 2310 2318
23. Drobyski WR Ash RC Casper JT Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukaemia Blood 83 1994 1980 1987
24. Enright H Davies S DeFor T Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukaemia: early transplantation, use of an unrelated donor and chronic graft-versus-host disease are predictive Blood 88 1996 714 720
25. Faber LM van Luxemburg-Heijs SA Willemz R Falkenberg JH Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia Journal of Experimental Medicine 176 1992 1283 1289
26. Faber LM van Luxemburg-Heijs SAP Veenhof WFJ Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity Blood 88 1995 2821 2828
27. Falkenburg JHF Goselink HM van der Harst D Growth inhibition of clonogeneic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes Journal of Experimental Medicine 174 1991 27 37
28. Falkenberg JHF Faber LM van der Elshout M Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation Journal of Immunotherapy 14 1993 305 309
29. Flowers MED Pepe MS Longton G Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic bone marrow transplantation British Journal of Haematology 74 1990 492 496
30. Gale RP Horowitz M Ash R Identical-twin bone marrow transplants for leukemia Annals of Internal Medicine 120 1994 646 652
31. Gallot G Hallet M Gaschet J Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host-graft-versus-leukemia reaction? Blood 88 1996 1098 1103
32. Giralt S Hester J Huh Y CD8-depleted donor lmphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 86 1995 4337 4343
33. Goldman J Gale RP Horowitz M Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion Annals of Internal Medicine 108 1988 806 814
34. Goulmy E Minor histocompatibility antigens and their role in transplantation Transplantation Reviews 2 1988 29 53
35. Goulmy E Schipper R Pool J Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after allogeneic bone marrow transplantation New England Journal of Medicine 334 1996 281 285
36. Grogg D Hahn S Erb P CD4+ T-cell-mediated killing of major histocompatibility complex class-II-positive antigen-presenting cells. III. CD4+ cytotoxic T-cells induce apoptosis of APC European Journal of Immunology 22 1992 267 274
37. Guerrassio A Martinelli G Saglio G Minimal residual disease status in transplanted chronic myelogenous leukaemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants Leukemia 6 1992 507 512
38. Guinan EC Gribben JG Boussiotis VA Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity Blood 84 1994 3261 3282
39. den Haan J Sherman N Blokland E Identification of a graft-versus-host disease associated human minor histocompatibility antigen Science 268 1995 1476 1480
40. van der Harst D Goulmy E Falkennburg F Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones Blood 83 1994 1060 1066
41. Hercend T Takvorian T Nowill A Characterization of natural killer cells with antileukemic activity following allogeneic bone marrow transplantation Blood 67 1986 722 730
42. Hessner M Endean D Casper J Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia Blood 86 1995 3987 3996
43. Higano CS Brixey M Bryant EM Durable complete remission of acute nonlymphoblastic leukaemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukaemia effect Transplantation 50 1990 175 177
44. Hoffman T Theobald M Bunjes D Frequency of bone marrow T cells responding to HLA identical non-leukemia and leukemic stimulators Bone Marrow Transplantation 12 1993 1 8
45. Horowitz MM Gale RP Sondel PM Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1991 555 562
46. Hoyle C Bangs CD Lane L Negrin R Generation of Ph-negative CD3+, CD56+ cytotoxic cells from patients with chronic phase (CP) CML: in vivo efficacy in SCID mice Blood 88 supplement 1 1996 675a
47. Jiang YZ Barrett AJ Cellular and cytokine-mediated effects of CD4-positive lymphocyte lines generated in vitro against chronic myelogenous leukaemia Experimental Hematology 23 1995 1167 1172
48. Jiang YZ Kanfer EJ Macdonald D Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T-lymphocytes reacting to host leukaemia cells Bone Marrow Transplantation 8 1991 253 258
49. Jiang YZ Cullis J Kanfar E T cell and NK cell mediated graft-versus-leukemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia Bone Marrow Transplantation 11 1993 133 138
50. Jiang YZ Mavroudis D Dermine S Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen British Journal of Haematology 93 1996 606 612
51. Jiang YZ Barett AJ Goldman JM Association of natural killer cell immune recovery with a graft-versus-leukaemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation Annals of Hematology 74 1997 1 6
52. Jiang YZ Mavroudis D Hensel N Barrett AJ Preferential usage of T cell receptor (TCR) Vβ by allogeneic T cells recognising myeloid leukamia cells: implications for separating GVL from GVHD Bone Marrow Transplantation 19 9 1997 899 903
53. Johnson BD Truitt RL Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease Blood 85 1995 3302 3312
54. Kagi D Vignaux F Ledermann B Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity Science 265 1994 528 530
55. Khene AG Advani SH Gengal SG in vitro generation of lymphocytotoxicity to autochthonous leukemia cells in chronic myelogenous leukemia British Journal of Cancer 43 1981 13 21
56. Kolb H-J Mitmuller J Clemm Ch Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462 2465
57. Kolb H-J Schattenberg A Goldman JM Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 86 1995 2041 2050
58. Lewalle P Hansel N Guimarães A Helper and cytotoxic T lymphocyte responses to chronic myeloid leukemia: implications for adoptive immunotherapy with T cells British Journal of Haematology 92 1996 587 594
59. Lin F van Rhee F Goldman JM Kinetics of increasing BCR-ABL transcript numbers in chronic mycloid leukemia patients who relapse after bone marrow transplantation Blood 87 1996 4473 4478
60. van Lochem E de Gast B Goulmy E In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities Bone Marrow Transplantation 30 1992 181 183
61. Mackall CL Granger L Sheard Ma T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymus-derived versus thymic-independent progeny Blood 82 1993 2585 2594
62. Mackinnon S Barnett L Bourhis JH Myeloid and lymphoid chimerism after T-cell depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA Blood 80 1992 3253 3260
63. Mackinnon S Barnett L Heller G O'Reilly RJ Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukaemia Blood 83 1994 3409 3416
64. Mackinnon S Papadopoulos E Carabasi M Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation separation of graft-versus-leukemia responses from graft-versus-host disease Blood 86 1995 1261 1268
65. Marmont AM Horowitz MM Gale RP T-cell depletion of HLA-identical transplants in leukaemia Blood 78 1991 2120 2130
66. Mavroudis DA Jiang YZ Hensel N Specific depletion of alloreactivity against haplotype mismatched related individuals: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation Bone Marrow Transplantation 17 1996 793 799
67. Mavroudis DA Dermime S Jiang YZ Selective immunodepletion between HLA matched siblings that reduces the risk for GVHD and preserves reactivity against the leukemia and Epstein-Barr virus Blood 88 supplement 1 1996 254a
68. Mehta J Powles RL Singhal S Tait D Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation Bone Marrow Transplantation 16 1995 133 138
69. Miyamura K Barrett AJ Kodera Y Saito H Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results Bone Marrow Transplantation 14 1994 201 209
70. Molldrem J Dermime S Parker K Targeted T cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells Blood 88 1996 2450 2457
71. Munker R Lubbert M Yonehara S Expression of the fas antigen on primary human leukemia cells Annals of Hematology 70 1995 15 22
72. Naparstek E Or R Nagler A T-cell depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse British Journal of Haematology 89 1995 506 515
73. Oettel K Wesly O Albertini M Allogeneic T-cell clones able to selectively destroy Philadelphia chromosome-bearing (Ph+) human leukemia lines can also recognize Ph- cells from the same patient Blood 83 1994 3390 3402
74. Pardoll DM Tumor antigens: a new look for the 1990's Nature 369 1994 357 358
75. Pawelec G Ehninger G Schmidt H Susceptibility of autologous target cells to lysis by lymphokine activated effectors from interferon treated chronic myelogenous leukemia patients Cancer Immunology and Immunotherapy 32 1990 167 172
76. Pawelec G Kalbacher H Bruserud O Tumour-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocations Oncology Research 4 1992 315 320
77. Perreault C Decary F Brochu S Minor histocompatibility antigens Blood 76 1990 1269 1277
78. Porter DL Roth MS McGarigle C Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukaemia New England Journal of Medicine 330 1994 100 106
79. Rencher SD Houston JA Lockey TD Eliminating graft-versus-host potential from T cell immunotherapeutic populations Bone Marrow Transplantation 18 1996 415 420
80. van Rhee F Feng L Cullis JO Relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation: the case for giving donor leukocyte transfusions before the onset of hematological relapse Blood 83 1994 3337 3383
81. (in press) van Rhee F Szydlo R Hermans J Long term results after allogeneic bone marrow transplantation for chronic myeloid leukaemia Bone Marrow Transplantation 1997
82. Roux E Helg C Dumont-Girard F Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and humanipulated grafts Blood 87 1996 3984 3992
83. Selleri C Sato T del Vecchio L Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukaemia Blood 89 1997 957 964
84. Somasundaram R Gengal G In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission Cancer, Immunology and Immunotherapy 27 1988 177 182
85. Stadler T Hahn S Erb P Fas antigen is the major target molecular for CD4+ T cell-mediated cytoxicity Journal of Immunology 152 1994 1127 1134
86. Storb R Deeg J Pepe M Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial Blood 73 1989 1729 1734
87. Sullivan KM Shulman HM Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories Transplantation Proceedings 21 1989 51 62
88. Sullivan KM Weiden PL Storb R Influence of acute and chronic graft-versus-host disease after relapse and survival after bone marrow transplantation from HLA identical siblings as treatment of acute and chronic leukemia Blood 73 1989 1720 1728
89. Teichmann JV Ludwig W-D Thiel E Cytotoxicity of IL-2 induced lymphokine activated killer (LAK) cells against human leukemia and augmentation of killing by interferon and tumor necrosis factor Leukemia Research 16 1992 287 298
90. Tiberghien P Reynolds CW Keller J Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84 1994 1333 1341
91. Topalian SL MHC II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy Current Opinion in Immunology 6 1994 741 745
92. Voogt PJ Goulmy E Fibbe WE Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells Journal of Clinical Investigation 82 1988 906 912
93. Weiden PL Flournoy N Thomas ED Antileukemic effects of graft versus host disease in human recipients of allogeneic marrow grafts New England Journal of Medicine 300 1979 1068 1073
94. Weiden P Sullivan K Flournoy N Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation New England Journal of Medicine 304 1981 1529 1531
95. Witherspoon RP Lum LG Storb R Thomas ED In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T- and non- T lymphocyte function within 3–4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy Blood 59 1982 844 850